We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$69.2B
AUM Growth
+$1.83B
(+2.7%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
2,040
New
475
Increased
982
Reduced
499
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$171M |
| 2 |
Moderna
MRNA
|
+$147M |
| 3 |
Exelon
EXC
|
+$113M |
| 4 |
Waters Corp
WAT
|
+$91.6M |
| 5 |
ANSS
Ansys
ANSS
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Extra Space Storage
EXR
|
+$128M |
| 2 |
A.O. Smith
AOS
|
+$104M |
| 3 |
Enphase Energy
ENPH
|
+$93.8M |
| 4 |
Evergy
EVRG
|
+$81.1M |
| 5 |
Dominion Energy
D
|
+$80.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.93% |
| 2 | Healthcare | 17.36% |
| 3 | Industrials | 15.16% |
| 4 | Utilities | 11.76% |
| 5 | Consumer Discretionary | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Aurinia Pharmaceuticals
AUPH
$2.06B
| $82K | ﹤0.01% |
+18,875
| New | +$110K |
|
1902
Opko Health
OPK
$1.04B
| $82K | ﹤0.01% |
65,495
+30,895
| +89% | +$48.7K |
|
1903
Brookdale Senior Living
BKD
$3.1B
| $81K | ﹤0.01% |
29,569
+16,369
| +124% | +$61.2K |
|
1904
GoPro
GPRO
$106M
| $81K | ﹤0.01% |
+16,196
| New | +$85K |
|
1905
Rocket Lab Corp
RKLB
$51.9B
| $81K | ﹤0.01% |
+21,434
| New | +$93.6K |
|
|
SAFE
1906
Safehold
SAFE
$1.09B
| $81K | ﹤0.01% |
+1,691
| New | +$81.5K |
|
1907
TETRA Technologies
TTI
$1.29B
| $81K | ﹤0.01% |
+23,359
| New | +$90.9K |
|
|
TELL
1908
DELISTED
Tellurian Inc.
TELL
| $81K | ﹤0.01% |
48,350
+14,702
| +44% | +$36.8K |
|
|
CHS
1909
DELISTED
Chicos FAS, Inc.
CHS
| $81K | ﹤0.01% |
+16,481
| New | +$92.7K |
|
|
TUYA
1910
Tuya Inc
TUYA
$1.1B
| $80K | ﹤0.01% |
+42,057
| New | +$51.1K |
|
|
LGF.B
1911
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $80K | ﹤0.01% |
+14,808
| New | +$98.2K |
|
1912
Compass
COMP
$9.77B
| $79K | ﹤0.01% |
33,864
+23,048
| +213% | +$60.5K |
|
1913
Textron
TXT
$15.3B
| $79K | ﹤0.01% |
76,980
+50,008
| +185% | +$3.4M |
|
1914
Seres Therapeutics
MCRB
$47.4M
| $77K | ﹤0.01% |
+685
| New | +$91.8K |
|
|
EB
1915
DELISTED
Eventbrite
EB
| $76K | ﹤0.01% |
+13,000
| New | +$85K |
|
1916
Gran Tierra Energy
GTE
$331M
| $76K | ﹤0.01% |
7,642
+4,588
| +150% | +$54K |
|
1917
MaxCyte
MXCT
$136M
| $76K | ﹤0.01% |
+14,535
| New | +$89.1K |
|
|
OLO
1918
DELISTED
Olo Inc
OLO
| $76K | ﹤0.01% |
+12,099
| New | +$91.3K |
|
|
PTRA
1919
DELISTED
Proterra Inc. Common Stock
PTRA
| $76K | ﹤0.01% |
+20,198
| New | +$107K |
|
|
ORGN
1920
DELISTED
Origin Materials
ORGN
| $75K | ﹤0.01% |
+546
| New | +$86.9K |
|
|
AGEN
1921
Agenus
AGEN
$311M
| $74K | ﹤0.01% |
1,580
+948
| +150% | +$48.2K |
|
|
SGMO
1922
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $74K | ﹤0.01% |
+23,462
| New | +$91.1K |
|
|
BRMK
1923
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $73K | ﹤0.01% |
+20,514
| New | +$95.5K |
|
1924
FIGS
FIGS
$2.4B
| $72K | ﹤0.01% |
+10,703
| New | +$77K |
|
1925
Senseonics Holdings Inc
SENS
$419M
| $72K | ﹤0.01% |
3,514
+2,466
| +235% | +$56.9K |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q4 2022 Portfolio in Review
As of Q4 2022, Pictet Asset Management (Switzerland) held 2,040 positions worth $69.2B, up 2.7% from $67.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Pictet Asset Management (Switzerland)'s Q4 2022 filing shows 475 new, 982 increased, 499 reduced and 56 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,121,765 shares worth $41.4M. The largest sale was Extra Space Storage, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q4 2022 buy was Amylyx Pharmaceuticals: 1,121,765 shares worth $41.4M.
- Pictet Asset Management (Switzerland) added most to Equinix in Q4 2022, an estimated $171M increase.
- Pictet Asset Management (Switzerland)'s biggest Q4 2022 reduction was Extra Space Storage, cutting an estimated $128M.
- Pictet Asset Management (Switzerland) fully exited Nomad Foods in Q4 2022, selling an estimated $49.5M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 14% of its $69.2B portfolio in Q4 2022.
- Pictet Asset Management (Switzerland) opened 475 new positions and closed 56 in Q4 2022.
- Pictet Asset Management (Switzerland)'s portfolio value rose 2.7% quarter-over-quarter to $69.2B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.